Skip to main content

Advertisement

Table 1 General characteristics and clinicopathological features of brain tumor patients and control subjects

From: A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas

Variables Controls(n = 15) Gliomas(n = 22) Meningiomas (n = 8)
Age mean 51 54 61
range 29–65 24–82 27–76
Gender males 8 12 3
females 7 10 5
Neurological disordersa _ 6 _
Grade II/III _ 12 _
IV _ 10 _
IDH1 mutationb c _ 6 _
IDH2 mutationc _ 0 _
MGMT promoter methylatedd _ 12 _
  1. a Hemisyndrome, psychiatric disorders, cognitive disorders
  2. b mutation r132h
  3. c 19 out of 22 patients analyzed for this mutations d MGMT promoter was considered methylated if the percentage of methylation was >5 %
  4. 14 out of 22 patients analyzed for methylation